Executive Summary

This section describes the classification of, and rules around, generic medicines within the EU. We explain the market access process for generics, and the different pricing and reimbursement models used in the EU5 countries. We also discuss moves around Europe to positively encourage prescription of generic medicines when the option exists, particularly for cost saving reasons.